Join
Live feed
·
NEWSReleasevia Quantisnow
Pluristem Therapeutics Inc. logo

Alliance Global Partners Maintains Buy on Pluristem Therapeutics, Lowers Price Target to $4

ByQuantisnow·Wall Street's wire, on your screen.
PSTI· Pluristem Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PSTI (Pluristem Therapeutics Inc.) and more on Quantisnow.